Keywords
Somatotropin, Legislative intent, Off label prescribing, Food, Drug and Cosmetic Act, Growth Hormone deficiency (GHd), Human growth hormone (hGH), Controlled Substances Act, Administrative deference, Physicians, United States
Somatotropin, Legislative intent, Off label prescribing, Food, Drug and Cosmetic Act, Growth Hormone deficiency (GHd), Human growth hormone (hGH), Controlled Substances Act, Administrative deference, Physicians, United States
Pages | 191-217 |
---|---|
Publication | Washington University Journal of Law & Policy |
Published | 2008-01-01 |
---|
This article has not been peer reviewed.